Announcements Trials

Browse Landscape

Phase

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 12 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Neoplasms 2 Neoplasm Metastasis 2 Multiple Myeloma 2 Glioblastoma 2 Carcinoma, Non-Small-Cell Lung 2 Astrocytoma 2 Urologic Neoplasms 1 Urologic Diseases 1 Urogenital Neoplasms 1 Thrombocytosis 1 Sarcoma, Ewing 1 Sarcoma 1 Recurrence 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Pancreatic Neoplasms 1 Oligodendroglioma 1 Neoplasms, Neuroepithelial 1 Neoplasms, Glandular and Epithelial 1 Neoplasms by Site 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Medulloblastoma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic-Phase 1

Interventions

Fulvestrant 2 tusamitamab ravtansine 1 palbociclib 1 nirogacestat 1 exemestane 1 Tamoxifen 1 Letrozole 1 Gemcitabine 1 Docetaxel 1 Capecitabine 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Breast Cancer Metastatic × palbociclib × Clear all

NCT03322215 2024-03-08

PASIPHAE

Karolinska University Hospital

Phase 2 Terminated

Breast Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡